NRXPW
NRx Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.01
+0.00%Margins
Gross margin
37.1%
EBITDA margin
-1017.5%
EBIT margin
-749.7%
Net margin
-1070.3%
FCF margin
-651.0%
177.6%
Return on equity
-206.2%
Return on assets
133.4%
Return on invested capital
0.18x
Asset turnover
-$14.9M
Cash from operations
$0.30
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026